Axim Biotechnologies Stock Market Value
| AXIM Stock | USD 0.01 0 15.38% |
| Symbol | Axim |
Axim Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Axim Biotechnologies' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Axim Biotechnologies.
| 11/25/2025 |
| 02/23/2026 |
If you would invest 0.00 in Axim Biotechnologies on November 25, 2025 and sell it all today you would earn a total of 0.00 from holding Axim Biotechnologies or generate 0.0% return on investment in Axim Biotechnologies over 90 days. Axim Biotechnologies is related to or competes with Unidoc Health, and Devonian Health. AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, an... More
Axim Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Axim Biotechnologies' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Axim Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 12.64 | |||
| Information Ratio | 0.0271 | |||
| Maximum Drawdown | 76.67 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 21.43 |
Axim Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axim Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Axim Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Axim Biotechnologies historical prices to predict the future Axim Biotechnologies' volatility.| Risk Adjusted Performance | 0.0347 | |||
| Jensen Alpha | 0.3476 | |||
| Total Risk Alpha | (0.81) | |||
| Sortino Ratio | 0.029 | |||
| Treynor Ratio | 0.3444 |
Axim Biotechnologies February 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0347 | |||
| Market Risk Adjusted Performance | 0.3544 | |||
| Mean Deviation | 8.49 | |||
| Semi Deviation | 8.82 | |||
| Downside Deviation | 12.64 | |||
| Coefficient Of Variation | 3020.57 | |||
| Standard Deviation | 13.5 | |||
| Variance | 182.33 | |||
| Information Ratio | 0.0271 | |||
| Jensen Alpha | 0.3476 | |||
| Total Risk Alpha | (0.81) | |||
| Sortino Ratio | 0.029 | |||
| Treynor Ratio | 0.3444 | |||
| Maximum Drawdown | 76.67 | |||
| Value At Risk | (15.79) | |||
| Potential Upside | 21.43 | |||
| Downside Variance | 159.87 | |||
| Semi Variance | 77.78 | |||
| Expected Short fall | (16.00) | |||
| Skewness | 1.66 | |||
| Kurtosis | 5.82 |
Axim Biotechnologies Backtested Returns
Axim Biotechnologies appears to be out of control, given 3 months investment horizon. Axim Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.018, which signifies that the company had a 0.018 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Axim Biotechnologies, which you can use to evaluate the volatility of the firm. Please makes use of Axim Biotechnologies' Risk Adjusted Performance of 0.0347, mean deviation of 8.49, and Downside Deviation of 12.64 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Axim Biotechnologies holds a performance score of 1. The firm shows a Beta (market volatility) of 1.27, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Axim Biotechnologies will likely underperform. Please check Axim Biotechnologies' total risk alpha and the relationship between the potential upside and period momentum indicator , to make a quick decision on whether Axim Biotechnologies' price patterns will revert.
Auto-correlation | -0.23 |
Weak reverse predictability
Axim Biotechnologies has weak reverse predictability. Overlapping area represents the amount of predictability between Axim Biotechnologies time series from 25th of November 2025 to 9th of January 2026 and 9th of January 2026 to 23rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Axim Biotechnologies price movement. The serial correlation of -0.23 indicates that over 23.0% of current Axim Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.